Stay updated on Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Location information updated: a new Locations heading appears and specific state sites (Georgia, Illinois, New Jersey, New York) are listed. State-specific subsections were removed, and the revision updated to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-19T13:59:31.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 with no visible changes to content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T05:57:14.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Minor administrative updates: a note stating that publications are automatically filled from PubMed and a new Revision: v3.3.1; these changes do not affect the study details, and to avoid alerts for small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-21T02:18:14.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Removed the general government funding/operating status notice from the page; study details remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-13T22:53:13.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    No significant changes detected on the Study Details page for NCT03077828. The title, objectives, eligibility criteria, and locations appear unchanged.
    Difference
    0.3%
    Check dated 2025-10-30T15:22:09.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    Major update: page version bumped to v3.2.0 and a government funding operating-status notice added; previous v3.0.2 revision removed.
    Difference
    3%
    Check dated 2025-10-02T01:25:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.